Clinical Trials

Gallbladder Neoplasms, Cholangiocarcinoma

NCT04907643 2026-02-20

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

EndocrineGastrointestinalNET

360 enrolled

Cancer Pain, Anus Neoplasms, Appendiceal Neoplasms, Bile Duct Neoplasms, Biliary Tract Neoplasms, Carcinoid Tumor, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Stomach Neoplasms, Neuroendocrine Tumors, Visceral Pain

NCT07146646 2026-02-19

Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer

27 enrolled

BreastEndocrineGastrointestinalGenitourinaryGynecologicNETSarcoma

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT05000294 2026-02-18

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

Phase 1/2 Suspended

29 enrolled

Bile Duct Neoplasms, Breast Neoplasms, Gallbladder Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vulvar Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT04203160 2025-12-31

Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04)

Phase 1/2 Terminated

75 enrolled 17 charts

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT06715839 2025-12-31

Target-specific immunoPET Imaging of Digestive System Carcinoma

400 enrolled

Phase 2 Enrolling by invitation

Simpson-Golabi-Behmel syndrome, Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Digestive System Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT07310069 2025-12-30

TRANSFORM-GBC

44 enrolled

Phase 2 Active not recruiting

Gallbladder Neoplasms

NCT02151084 2025-12-16

A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer

57 enrolled

Phase 1/2 Not yet recruiting

Gallbladder Neoplasms, Recurrence

NCT07269158 2025-12-08

A Phase IIb Randomized Clinical Trial of Immune Checkpoint Inhibitor-based Maintenance Therapy in Patients With Advanced Biliary Tract Cancer

160 enrolled

Phase 1 Active not recruiting

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT03257761 2025-12-05

Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer

55 enrolled

Phase NA Active not recruiting

Gallbladder Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Cholangiocarcinoma

NCT02293954 2025-11-14

Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer

20 enrolled 8 charts

BreastGastrointestinalThoracic

Bile Duct Neoplasms, Breast Neoplasms, Colonic Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Rectal Neoplasms, Carcinoma, Medullary

NCT02495896 2025-11-10

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

Phase 1 Active not recruiting

61 enrolled

GastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Gallbladder Neoplasms, Pancreatic Neoplasms

NCT06123117 2025-09-11

STALL

850 enrolled

Cholecystitis, Cholelithiasis, Gallbladder Neoplasms

NCT06246448 2025-09-05

ROBOCOP

94 enrolled

Gallbladder Neoplasms

NCT06178445 2025-08-19

TRAP-BTC

24 enrolled

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT07025174 2025-06-17

SAIB

60 enrolled

Phase 2/3 Not yet recruiting

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT06999512 2025-05-31

HPB70+

526 enrolled

Phase 2 Active not recruiting

Gallbladder Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms

NCT06638931 2025-05-28

ANTARES

28 enrolled

BreastCNSEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckNETOther solid neoplasmSarcomaThoracic

Urachal adenocarcinoma, Urachal cancer, Fibrolamellar hepatocellular carcinoma, Secretory breast carcinoma, Carcinoma, Ovarian Epithelial, Adrenal Gland Neoplasms, Anus Neoplasms, Biliary Tract Neoplasms, Carcinosarcoma, Carcinoma, Adenoid Cystic, Fallopian Tube Neoplasms, Fibrosarcoma, Gallbladder Neoplasms, Granulosa Cell Tumor, Hemangiosarcoma, Leiomyosarcoma, Mesothelioma, Neuroblastoma, Parathyroid Neoplasms, Penile Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Thyroid Neoplasms, Trophoblastic Neoplasms, Urethral Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Hepatoblastoma, Endodermal Sinus Tumor, Neuroectodermal Tumors, Primitive, Cholangiocarcinoma, Sertoli-Leydig Cell Tumor, Neurofibrosarcoma, Hemangioblastoma, Neuroendocrine Tumors

NCT06963060 2025-05-08

GALENT-BT

Phase 2 Enrolling by invitation

44 enrolled

Gallbladder Neoplasms, Cholangiocarcinoma

NCT05239169 2025-05-01

Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer

40 enrolled

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT06712420 2025-04-16

NEOGB

Phase 3 Recruiting

114 enrolled

Gallbladder Neoplasms

NCT06214572 2025-04-11

RUGB

Phase 2/3 Recruiting

249 enrolled

Phase 3 Active not recruiting

Biliary Tract Neoplasms, Gallbladder Neoplasms

NCT02170090 2025-03-30

ACTICCA-1

789 enrolled

Phase 2 Enrolling by invitation

Gallbladder Neoplasms, Cholangiocarcinoma

NCT06901622 2025-03-30

Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma

50 enrolled

Gallbladder Neoplasms, Cholangiocarcinoma

NCT04484636 2025-03-20

PLATON

Phase NA Completed

400 enrolled

Phase NA Not yet recruiting

Esophageal Neoplasms, Gallbladder Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Cholangiocarcinoma

NCT06787807 2025-01-22

Proteomic Analysis of Patients Undergoing Bariatric Surgery

103 enrolled

BreastCNSGastrointestinalGenitourinaryGynecologicHead & NeckOtherPlasma cell

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Kidney Neoplasms, Liver Neoplasms, Meningioma, Multiple Myeloma, Neoplasms, Obesity, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms

NCT06101277 2025-01-06

LIVELONG

300 enrolled

Appendiceal Neoplasms, Biliary Tract Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT04164069 2024-12-27

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

9 enrolled

Phase 2 Active not recruiting

Bile Duct Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT06717464 2024-12-05

Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer

110 enrolled

Phase 3 Enrolling by invitation

Gallbladder Neoplasms, Klatskin Tumor

NCT06671418 2024-11-04

TESLA RCT

148 enrolled

Gallbladder Neoplasms

NCT05833815 2024-08-13

Addition of Everolimus to Standard of Care in Carcinoma Gallbladder

Phase 2/3 Recruiting

56 enrolled

DermatologicGastrointestinalOther solid neoplasmThoracic

Gallbladder Neoplasms

NCT02714374 2024-08-06

GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers

Phase 1 Terminated

5 enrolled

Gallbladder Neoplasms, Melanoma, Mesothelioma, Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT02920554 2024-05-22

The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer

88 enrolled

Gallbladder Neoplasms

NCT00486356 2024-01-03

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

46 enrolled

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Stomach Neoplasms

NCT01825603 2023-12-28

ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer

17 enrolled

Gallbladder Neoplasms, Pancreatic Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT06134193 2023-11-18

Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer

41 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologic

Carcinoma, Gallbladder Neoplasms, Cholangiocarcinoma

NCT04534309 2023-10-10

ASPIRE

Phase NA Completed

340 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Gallbladder Neoplasms, Kidney Neoplasms, Melanoma, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

NCT06013943 2023-09-15

Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBC

30 enrolled

Gallbladder Neoplasms

NCT05681949 2023-08-24

ADBoard

Phase NA Unknown

1,200 enrolled

Fibrolamellar hepatocellular carcinoma, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Cholangiocarcinoma, Klatskin Tumor

NCT04072445 2023-08-09

Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer

28 enrolled 20 charts

Bile Duct Neoplasms, Gallbladder Neoplasms

NCT03278106 2023-06-28

TAS-102 in Treating Advanced Biliary Tract Cancers

28 enrolled 12 charts

Gallbladder Neoplasms, Cholangiocarcinoma

NCT02520141 2023-06-15

Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery

61 enrolled 9 charts

Gallbladder Neoplasms, Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT03473574 2023-06-15

IMMUCHEC

128 enrolled

Gallbladder Neoplasms, Cholangiocarcinoma

NCT02333188 2023-05-31

Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer

50 enrolled

Gallbladder Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Cholangiocarcinoma

NCT02351765 2023-05-17

ABC-08

21 enrolled

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT02174575 2023-05-03

Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery

Phase 4 Withdrawn

Gallbladder Neoplasms, Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT04211168 2023-03-29

Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers

44 enrolled

Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT05757336 2023-03-07

Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer

50 enrolled

Gallbladder Neoplasms

NCT05620498 2022-11-17

Tislelizumab Combined With Lenvatinib and GEMOX Versus Tislelizumab Combined With GEMOX in Conversion Therapy of ICC and GBC.

60 enrolled

Gallbladder Neoplasms

NCT02489422 2022-10-14

PRO-YOU

Phase NA Completed

44 enrolled 28 charts